晚期肺癌中的抗体-药物结合物:这是一个新的前沿吗?
Joshua E Reuss1, Samuel Rosner2, Benjamin P Levy3
1Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.
Clinical advances in hematology & oncology : H&O
|May 28, 2024
概括
抗体 - 药物合物 (ADC) 通过提供向的细胞毒性有效载荷,为高级非小细胞肺癌 (NSCLC) 提供了一种新的策略. 需要进一步的研究,以充分了解它们的机制,优化使用,并管理NSCLC治疗中的毒性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 先进的非小细胞肺癌 (NSCLC) 治疗已经被向疗法和免疫疗法彻底改变.
- 尽管取得了进展,但在管理先进的NSCLC方面仍然存在重大未满足的需求.
- 抗体-药物合物 (ADC) 正在成为NSCLC的有前途的治疗策略.
研究的目的:
- 审查NSCLC中ADCs的生物学,结构和作用机制.
- 检查目前和潜在的ADC目标以及NSCLC的组合策略.
- 为了解决有关在NSCLC中ADC使用的关键未回答的问题.
主要方法:
- 关于NSCLC中ADCs的临床前和临床研究的文献综述.
- 对已批准和正在研究的ADC标及其相关抗原进行分析.
- 讨论新兴的策略,耐药性机制和毒性管理.
主要成果:
- ADCs通过抗体向选择性地向癌细胞传递细胞毒性有效载荷.
- 目前对ADC机制的理解还处于起步阶段,需要进一步研究.
- 几种ADC标已被批准或正在进行NSCLC治疗的调查.
结论:
- ADCs代表了NSCLC治疗的重大进步,提供向细胞毒性.
- 进一步的研究对于阐明ADC机制,确定最佳生物标志物和完善治疗序列至关重要.
- 解决耐药性和管理ADC特异性毒性是最大化NSCLC治疗益处的关键.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515


